Form 4 Filing for Aquestive Therapeutics, Inc.

This filing details a derivative transaction where John Cochran was granted 50,500 stock options for common stock at a price of $0.00 per share, with an exercise date of June 10, 2027, and an expiration date of June 10, 2036. The underlying shares vest fully on June 10, 2027, contingent upon continued service. Post-transaction, 50,500 shares are owned under this option. Additionally, Cochran holds 99,486 common shares directly. The filing also includes a Power of Attorney document authorizing specific individuals to execute and file necessary SEC forms (3, 4, 5, and 144) on behalf of the reporting owner.